| | | | | | | | | | | | | | | | | | | | | |
Ownership Document |
Schema Version: X0508 |
Document Type: 4 |
Period of Report: 2/27/24 |
Issuer: |
| Issuer CIK: 730272 |
| Issuer Name: REPLIGEN CORP |
| Issuer Trading Symbol: RGEN |
Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1754555 |
| | Owner Name: Garland Jason K |
| Reporting Owner Address: |
| | Owner Street 1: C/O REPLIGEN CORPORATION |
| | Owner Street 2: 41 SEYON ST., BLDG 1, STE 100 |
| | Owner City: WALTHAM |
| | Owner State: MA |
| | Owner ZIP Code: 02453 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: CFO |
Aff 10b5 One? No |
Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 2/27/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 2,540 |
| Footnote ID: F1 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 8,043 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
Derivative Table: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Stock Option (Right to Buy) |
| | Conversion or Exercise Price: |
| | | Value: 192.71 |
| | Transaction Date: |
| | | Value: 2/27/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 2,523 |
| | | Transaction Price Per Share: |
| Value: 0.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Exercise Date: |
| | | Footnote ID: F2 |
| | Expiration Date: |
| | | Value: 2/27/34 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 2,523 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 2,523 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
Footnotes: |
| Footnote - F1: Mr. Garland was awarded 2,540 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. |
| Footnote - F2: One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026, and February 27, 2027. |
Owner Signature: |
| Signature Name: /s/ Kimberly Brown (Attorney in Fact) |
| Signature Date: 2/29/24 |